Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study
Author:
Affiliation:
1. Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel
2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3. Infectious Diseases Unit, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfab155/37961409/gfab155.pdf
Reference15 articles.
1. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA;Nephrol Dial Transplant,2021
2. The urgent need to vaccinate dialysis patients against SARS-CoV-2: A call to action;Francis;Kidney Int,2021
3. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021
4. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020
5. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation;Krueger;Am J Kidney Dis,2020
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients;Clinical Nephrology;2024-06-01
2. Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients;Microorganisms;2024-04-25
3. Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine;eLife;2024-04-24
4. Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis;Biomedical Reports;2024-03-19
5. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response;Management, Body Systems, and Case Studies in COVID-19;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3